Where does Benitec Biopharma Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Benitec Biopharma Limited ranks #34,448 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Benitec Biopharma Limited hold?

Benitec Biopharma Limited holds 7 US utility patents granted between 2015 and 2022, spanning 5 technology areas.

What is Benitec Biopharma Limited's Innovation Score?

Benitec Biopharma Limited has an Innovation Score of 35.0 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Benitec Biopharma Limited's patent grant rate increasing or decreasing?

Benitec Biopharma Limited's recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Benitec Biopharma Limited's patents?

Benitec Biopharma Limited's patents average 22.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Benitec Biopharma Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Benitec Biopharma Limited

Q: What technology areas does Benitec Biopharma Limited focus on?

Benitec Biopharma Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 7 patents, ranking #1,382 of 4,144 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Benitec ranks #34,448 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#34,448
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (35.0/100): 22.0
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34448 · US Corporation #34,448 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,448/49,997
PHOTO-FINISH Belite Bio
CPC-NARROW C12N · 5 areas
INNOV-THIN 35.0/100
CLAIMS-DENSE 22.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Belite Bio, Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Benitec’s 35.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (21%) Velocity 6.7 pts (19%) Breadth 7.9 pts (23%) Claim depth 13.2 pts (38%)

Qualcomm Incorporated · highest

85
Benitec Biopharma · this assignee

35
Bercom International · near

35
DeWalch · near

35
J D Franco & · near

35
Jetoptera · near

35
3D Lighting… · lowest

7

What this shows Benitec's Innovation Score is 35.0/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Benitec?

Each dot is one of Benitec’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Benitec’s own 22.0 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Benitec vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Benitec's grants concentrate

Benitec Biopharma Limited is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Benitec sits between Belite Bio, Inc and Beyond Imagination Inc..

Benitec's three-year grant acceleration

Benitec Biopharma Limited shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Belite Bio

7
Bell Automotive P…

7
Bell Semiconductor

7
Benbria

7
Bernhard Foerster

7
Beta-o2

7
Beyond Identity

7
Beyond Imagination

7
Benitec Biopharma ◀

7

What this shows Benitec holds 7 patents at rank #34,518, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Benitec

By rank, the assignees closest to #34,518 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Benitec's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Benitec, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Benitec ranks #1,382 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

DeWalch Technologies, Inc. 35 Jetoptera, Inc. 35 J.D. Franco & Co., LLC 35 Bercom International, LLC 35

Benitec's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Benitec Biopharma Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	14.3%
2016	2	28.6%
2017	1	14.3%
2018	1	14.3%
2021	1	14.3%
2022	1	14.3%

Which technologies does Benitec Biopharma Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C12Y - Enzymes 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C07K - Peptides 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Benitec Biopharma Limited's patent record in context - here's where to go next.

Benitec Biopharma Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #34,448 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Benitec Biopharma Limited against Belite Bio, Inc, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.